Connect with us

Entrepreneur

‘You don’t need to have it all figured out’- the founder getting more women into tech

Published

on

Safa Jemai, founder and CEO of Víkonnekt

Safa Jemai knew she wanted to study computer science from a young age, but it wasn’t until she moved to Iceland from sunny Tunisia that she embarked on the journey of entrepreneurship, building the software and product development firm Víkonnekt. Here, she tells us how she got into tech and why she would like more women to do the same.

Safa, could you tell us a bit more about your background?

I was born in a middle class family in Bizerte, a small town in North Tunisia. My parents knew from the start that the only way to see their kids succeed in a tremendously challenging environment was to study and study very hard.

I was encouraged from a very early age to excel in maths, science and physics but later on when I was 12, I decided to take the path of computer science.

In 2018, I made the decision to move from Tunisia to Iceland to study the Icelandic language and continue my degree in computer science, receiving my degree in both from Iceland’s top university.

I had the opportunity to work on two projects that combined knowledge from my studies: a language processing project to preserve the Icelandic language in the age of AI – at a time when small nation languages have been at their most vulnerable – and entering a national incubator programme with a mobile app to help people more readily and easily learn Icelandic.

I put my focus on building two companies that serve multiple purposes, including fostering a diverse, inclusive tech industry and inspiring interests in different cultures and inclusivity across cultures.

What inspired you to create Vikonnekt?

I saw an opportunity in the market. While I was still in university, I worked also as a developer for a few start-ups and as a freelancer project manager.

I noticed the innovative ecosystem in Iceland is growing and we have more and more exciting companies with more entrepreneurs, but at the same time we have a need for more IT specialists.

I thought I could leverage my connections in Tunisia and build a strong team that could work remotely with another team based in Iceland and Víkonnekt was born.

I reached out to a few entrepreneurs and asked them about their experiences hiring tech people and implementing software products and in summer 2021, we officially launched Víkonnekt.

How would you describe Vikonnekt in a few words?

Víkonnekt is focused on providing third party technical development services to Nordic tech enterprises and companies and supporting the technical due diligence process for venture capital firms— as well as leveraging the technical development expertise of talented folks from Tunisia’s emerging technology sector.

 What makes Vikonnekt different?

Like other projects that I have been working on, Víkonnekt serves a multitude of purposes. Perhaps most notably, the company’s work showcases the new opportunities in North Africa by expanding the Nordic and European viewpoint of tech development, beyond Eastern Europe, and into the African continent.

Tech talent in Tunisia struggle with garnering fair, equitable salary negotiation. This results in significant immigration to European countries and destroys Tunisia’s ability to compete in the innovation sector.

As hybrid and remote work becomes more and more viable, and the normalisation of tech outsourcing to previously underutilised nations, like Tunisia, gains traction, Vikonnekt fosters regional economic development. This is reinforced by offering talent in Tunisia higher salaries and amenable work cultures than current market norms.

It enables talent to stay connected to their home cultures and reduces economic and housing challenges across Europe, improving work efficiency and better business outcomes.

Víkonnekt blends two seemingly unrelated and often underestimated cultures together, hiring talented people for compelling technical projects, both from Iceland and Tunisia. Though Tunisia is a big tech talent hub, it rarely has the chance to be showcased in European media and can be overshadowed by ecosystems in the Middle East.

Víkonnekt opens new doors of understanding of Tunisian possibilities for companies in Iceland and the Nordics, with regard to taking projects offshore or outsourcing. Víkonnekt also demonstrates to the emerging Tunisian tech sector the wealth of possibilities in collaborating with European and Nordic enterprises, expanding business opportunities for both regions.

It’s still quite rare for women to found tech entities in Europe, let alone garner success by bootstrapping. Even in Iceland, the reining utopia of gender equality, the number of female-founded tech companies remains relatively low. Compound this with additional distinctions, such as immigrant-founded, non-christian founded or non-white founded entities, and the stats drop to daunting levels.

With Víkonnekt, our aim is to eliminate barriers for non-white, non-christian, immigrant women technologists and entrepreneurs and help them thrive in the tech and business world.

It’s no secret that women are in the minority in the tech industry. How is Vikonnekt solving this issue?

While it is always a work in progress, our strategy has been from the beginning to search for female talent in universities.

We found it helpful to advertise for end term projects that students can work on with us and when they finish it, we hire them in the company. This way we are able to attract female developers more easily, as they feel more confident to apply for the end term projects, as well as train them well while working on the internal product through their end term project.

What are some of the ways to attract and retain women in tech that you discovered while building Vikonnekt?

Companies need to make sure that they provide a collaborative environment where voices are heard and opinions are taken seriously.

Through my journey with Vikonnekt, I noticed that women tend to listen more than talk. This is good, but it tends to create some imbalance – all team members need to communicate their thoughts out loud and influence the decisions of the company.

Here comes the responsibility of managers to notice these behaviours and create a safe space for everyone to listen and speak as well. When female developers see that their opinions matter and they are heard then they appreciate that a lot and tend to choose to stay in that company as they know that when they speak, they will be heard. People in general don’t seek only high salaries or bonuses but also a place where they are respected and taken seriously.

What is something you wish you learned sooner about the tech industry?

I wish I was taught early in school that I don’t have to figure out everything from the beginning to be able to participate in cool projects. Confidence is more important than knowledge in most cases. People trust a more confident person even if they might be making a wrong decision.

I think we need to teach our kids to be confident and communicate their thoughts early on even if they don’t have the right answers.

What advice would you give to people in the tech industry looking to diversify their tech talent pipeline?

Attracting tech talent doesn’t start in universities, it requires much more effort. If societies want to reach more people, they need to start earlier in the process which means in primary schools – that’s where kids start developing their passions.

Governments could arouse kids’ curiosity through programmes in their studies either through schools or associations. My passion for tech started when I was still 12 as I joined the local association in my hometown where I had the chance to work on simple IT projects. Having not taken part in the association, where I started familiarising myself with creating simple software projects, and having not chosen computer science in high school, I would have not chosen to build a career in the tech industry.

When we ask kids what they want to be when they grow up, they tend to lean more towards jobs like a doctor, teacher or an astronaut – that’s because the environment introduces them to these positions at a very early age.

How about we use the same tactic and introduce them to software development when they are still young? I am not talking about familiarising them with using social media but much more than that; I am talking about helping them understand how these programmes are actually built.

To receive the Femtech World newsletter, sign up here.

Entrepreneur

Sun Pharma to acquire Organon in US$11bn deal

Published

on

Indian pharmaceutical giant Sun Pharma has agreed to buy Organon for US$11.75bn in a deal aimed at expanding its women’s health and biosimilars business.

Organon, which was spun out of Merck in 2021, has built a portfolio of more than 70 women’s health and general medicines products, including biosimilars, sold in the US and about 140 other countries.

The acquisition would give Sun Pharma a broader presence in biosimilars, which are medicines designed to be highly similar to existing biological drugs, and strengthen its position in women’s health.

Dilip Shanghvi, executive chairman of Sun Pharma, said: “Organon’s portfolio, capabilities, and global reach are highly complementary to our own, and we believe that bringing the two organizations together can create a stronger and more diversified platform.”

The companies said the combined business would generate annual revenue of US$12.4bn, operate across 150 countries and rank among the top three companies globally in women’s health.

They also said it would become the seventh largest biosimilar player.

Sun Pharma said the deal would help grow its innovative medicines business and expand its biosimilars offering.

It added that the combined company would have 18 large markets each generating more than US$100m in revenue.

Organon’s largest markets include the US, Brazil, Canada, China and countries in the European Union. The company also has six manufacturing facilities across the EU and emerging markets.

The deal follows market speculation that began on 10 April, when Indian media reported that Sun Pharma had submitted an all-cash offer for Organon.

A later report said the offer had been revised to US$13bn. Sun Pharma shares rose about 7 per cent on India’s National Stock Exchange after the announcement.

Sun Pharma said it would acquire all of Organon’s issued and outstanding shares in cash, using a combination of available cash and committed bank financing. It also estimated synergies of about US$350m within two to four years of completion.

The company said the acquisition would strengthen its cash generation, with EBITDA and cash flow set to nearly double, supporting efforts to reduce the net debt to EBITDA ratio of 2.3 times resulting from the deal. EBITDA is a measure of operating performance before certain costs are deducted.

Organon reported revenue of US$6.2bn last year and adjusted EBITDA of US$1.9bn. It also reported debt of US$8.64bn, down from US$9.5bn when it separated from Merck, and a cash balance of US$574m.

In November, Organon announced plans to sell its JADA System, designed to control and treat abnormal postpartum uterine bleeding or haemorrhage, to Laborie Medical Technologies for up to US$465m. Net proceeds from the sale will contribute to Organon’s cash balance as of 31 March 2026.

Organon will merge with a subsidiary of Sun Pharma, with Organon surviving the merger. The boards of both companies have approved the transaction.

Carrie Cox, executive chair of Organon, said: “Following a comprehensive review of strategic alternatives, our Board determined that this all-cash transaction offers compelling and immediate value to Organon stockholders.”

The transaction is expected to close in early 2027, subject to regulatory approvals and Organon stockholder approval.

Continue Reading

News

Women’s digital health market set to reach US$5.28 billion in 2026 – report

Published

on

The women’s digital health market is set to reach US$5.28bn in 2026, up from US$4.36bn in 2025, according to a new report.

That would represent annual growth of 20.9 per cent, driven by factors including greater smartphone use among women, wider uptake of telehealth and a stronger focus on preventive care.

The report said the market could reach US$11.47bn by 2030, with projected annual growth of 21.4 per cent over the forecast period.

It also pointed to rising awareness of gender-specific health needs, expansion among digital health start-ups, growing demand for personalised healthcare, investment in femtech innovation and the spread of AI-enabled diagnostics.

Wearables linked to health apps and wider use of remote monitoring tools are also expected to play a larger role, as companies focus on more preventive and joined-up care.

Smartphone use was highlighted as a major driver because mobile apps are increasingly being used for women’s health services, from menstrual cycle tracking to pregnancy support.

The report cited Eurostat data showing that in 2023, 89 per cent of EU residents aged 16 to 74 in urban areas accessed the internet via smartphones.

The report also said companies in the sector are developing new technology aimed at improving access to more personalised healthcare.

One example it gave was a 2024 collaboration between Algorand and the Self-Employed Women’s Association to launch a digital health passport for women in India’s informal economy using blockchain technology.

Recent mergers and acquisitions were also noted. In March 2023, Maven Clinic acquired Naytal to expand its services in the UK and Europe.

North America was identified as the largest market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Companies named as key players included Flo Health Inc, Natural Cycles, Elvie, Bellabeat, Clue by Biowink, MobileODT Ltd., Glow, Veera Health, Biowink GmbH, Ava AG, Hims & Hers Health, Inc., The Women’s Wellness Centre, Elara Health, myGynaeDoc, Maven Clinic, Kindbody, Allara Health, Tia and Hera Med Ltd.

Continue Reading

Entrepreneur

Future Fertility raises Series A financing to scale AI tools redefining fertility care worldwide

Published

on

Future Fertility Inc. has announced the closing of a US$4.1 million Series A financing round.

The round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany) and Whitecap Venture Partners, with participation from new investors Sandpiper Ventures, Gaingels, and Jolt VC.

The financing will accelerate Future Fertility’s commercial expansion into Asia-Pacific and support its entry into the United States, including planned FDA 510(k) clearance for additional products as part of a broader U.S. market entry strategy.

Proceeds will also advance the development of a broader AI platform, from egg assessment through to embryo transfer, designed to support clinicians, embryologists, and patients across the full IVF journey.

M Ventures and Whitecap have supported Future Fertility’s mission to translate AI innovation into meaningful clinical outcomes since the company’s earliest stages.

Oliver Hardick, investment director, M Ventures, said: “Future Fertility is addressing a critical unmet need in reproductive medicine with a differentiated AI platform grounded in clinical data and real-world workflow integration.

“We are excited to continue supporting the company and team because we believe its technology has the potential to improve decision-making for clinicians, bring greater clarity to patients, and help advance a more personalised standard of care in fertility treatment.”

Future Fertility’s AI platform addresses a long-standing gap in fertility care: historically, there has been no objective, clinically validated method for assessing egg quality (Gardner et al., 2025), despite it being one of the most important drivers of reproductive success.

The company’s suite of deep learning tools includes VIOLET™, MAGENTA™, and ROSE™, purpose-built for egg freezing, IVF, and egg donation respectively.

The tools are based on AI models trained and validated on more than 650,000 oocyte images and are deployed in over 300 clinics across 35 countries.

Rhiannon Davies, founding and managing partner, Sandpiper Ventures, said:  “The best outcomes in fertility care globally come from better data and smarter tools. Future Fertility understands that, and they’ve built a platform that delivers on it.

“Sandpiper is proud to back a team turning rigorous science into real results for patients and clinicians alike.”

Partnerships with the world’s leading fertility networks – including IVI RMA and Eugin Group across Latin America and Europe, FertGroup Medicina Reproductiva in Brazil, and most recently announced Kato Ladies Clinic in Japan –  reflect growing demand for objective, AI-powered oocyte assessment in fertility care. In the United States, ROSE™ is newly available under an FDA 513(g) determination.

Research shows that approximately 50 per cent of IVF patients do not understand their likelihood of success, and many discontinue treatment prematurely, even though cumulative success rates improve significantly with multiple cycles (McMahon et al., 2024).

By delivering earlier clarity on egg quality, Future Fertility’s tools support more informed conversations between clinicians and patients, helping set realistic expectations and guide decisions about next steps.

Future Fertility’s growing evidence base spans seven peer-reviewed publications in Human Reproduction, Reproductive BioMedicine Online, Fertility & Sterility, and Nature’s Scientific Reports, and more than 70 scientific abstracts accepted and presented with partner clinics at conferences worldwide.

Christine Prada, CEO, Future Fertility, said: “Fertility treatment is one of the most emotionally and physically demanding experiences a person can go through.

“Every patient deserves objective data, not just a best guess, to support better decisions at critical moments in their care.

“This funding means we can bring that clarity to more patients, in more countries, at a moment when it matters most.”

Find out more about Future Fertility at futurefertility.com

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.